Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Molecular and Cellular Biology

• Publication date

  2000-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.20.20.7450-7459.2000PMID 11003642PMCID PMC86298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Negative feedback regulation of wild-type p53 biosynthesis

  2007cited by this paper
• Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

  1999cited by this paper
• Genetic analysis of BRCA1 function in a defined tumor cell line.

  1999cited by this paper
• Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

  1999cited by this paper
• Altered Regulation of Cyclin G in Human Breast Cancer and Its Specific Localization at Replication Foci in Response to DNA Damage in p53+/+ Cells*

  1999cited by this paper
• BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours

  1999cited by this paper
• Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

  1999cited by this paper
• The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter

  1999cited by this paper
• Brca1 controls homology-directed DNA repair.

  1999cited by this paper
• Growth Retardation, DNA Repair Defects, and Lack of Spermatogenesis in BRCA1-Deficient Mice

  1999cited by this paper
• DNA-dependent protein kinase acts upstream of p53 in response to DNA damage

  1998cited by this paper
• The p53 Tumor Suppressor Inhibits Transcription of the TATA-less Mouse DP1 Promoter*

  1998cited by this paper
• BRCA1, BRCA2, and DNA damage response: collision or collusion?

  1998cited by this paper
• BRCA1 physically associates with p53 and stimulates its transcriptional activity

  1998cited by this paper
• The genetics of breast cancer susceptibility.

  1998cited by this paper
• p53 facilitates pRb cleavage in IL‐3‐deprived cells: novel pro‐apoptotic activity of p53

  1998cited by this paper
• Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

  1998cited by this paper
• p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

  1998cited by this paper
• The p53 Network*

  1998influential reference
• Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression

  1998cited by this paper
• BRCA1 regulates p53-dependent gene expression.

  1998cited by this paper
• BRCA1 required for transcription-coupled repair of oxidative DNA damage.

  1998cited by this paper
• Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL

  1998cited by this paper
• Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor

  1997cited by this paper
• Binding and modulation of p53 by p300/CBP coactivators

  1997cited by this paper
• Synergistic activation of transcription by CBP and p53

  1997cited by this paper
• Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

  1997cited by this paper
• Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.

  1997cited by this paper
• Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage.

  1997influential reference
• Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

  1997cited by this paper
• Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutation

  1997cited by this paper
• BRCA1 is a component of the RNA polymerase II holoenzyme.

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• Databases on transcriptional regulation : TRANSFAC , TRRD and COMPEL

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997influential reference
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• DNA damage induces phosphorylation of the amino terminus of p53.

  1997cited by this paper
• A novel p53‐inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis

  1997cited by this paper
• Repression of p53-mediated transcription by MDM2: a dual mechanism.

  1997cited by this paper
• BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

  1997cited by this paper
• Complex Regulation of the BRCA1 Gene*

  1997cited by this paper
• p53; from inductive signal to cellular effect.

  1997cited by this paper
• p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction.

  1996cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• Wild-type p53 negatively regulates the expression of a microtubule-associated protein.

  1996cited by this paper
• mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

  1996cited by this paper
• Genetic determinants of p53-induced apoptosis and growth arrest.

  1996cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

  1996cited by this paper
• Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases

  1995cited by this paper
• Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases (*)

  1995cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper
• Allosteric activation of latent p53 tetramers.

  1994cited by this paper
• Database of p53 gene somatic mutations in human tumors and cell lines.

  1994cited by this paper
• Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway

  1994cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• Control of messenger RNA stability.

  1993cited by this paper
• Regulation of the specific DNA binding function of p53.

  1992cited by this paper
• Negative regulation of Rb expression by the p53 gene product.

  1992cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Wild-type p53 can down-modulate the activity of various promoters.

  1991cited by this paper
• Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.

  1989cited by this paper
• Control of messenger RNA stability.

  1987cited by this paper

• p53-deficient cancer cells hyperactivate DNA double-strand break repair pathways to overcome chemotherapeutic damage and augment survival

  2025cites this paper
• Breast cancer gene-1 (BRCA1) potentiates maladaptive repair after kidney injury.

  2025cites this paper
• BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM

  2025cites this paper
• Bisphenol A Promotes the Progression of Hormone-Sensitive Breast Cancers Through Several Inflammatory Pathways

  2025cites this paper
• Kaempferol Targets Global Epigenetic Modifiers to Impedes Growth and Migratory Ability of HeLa Cells

  2025cites this paper
• BRCA Mutations and MicroRNA Expression Patterns in the Peripheral Blood of Breast Cancer Patients

  2024cites this paper
• Radiosensitization effect of quinoline-indole-schiff base derivative 10E on non-small cell lung cancer cells in vitro and in tumor xenografts

  2024cites this paper
• Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment Strategies

  2024cites this paper
• Human Mammary Tumor Virus (HMTV) Reshapes Risk of Women Developing Breast Cancer: Re-visiting an Under considered Variable in Tumorigenesis of the Breast

  2024cites this paper
• PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis.

  2023cites this paper
• Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53.

  2023cites this paper
• BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature.

  2023cites this paper
• Treatment of Sulfur Mustard Corneal Injury by Augmenting the DNA Damage Response (DDR): A Novel Approach

  2023cites this paper
• A transcriptional program associated with cell cycle regulation predominates in the anti-inflammatory effects of CX-5461 in macrophage

  2022cites this paper
• ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress

  2022cites this paper
• KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player

  2022cites this paper
• VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor

  2022influential citation
• TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer

  2021cites this paper
• Gene dosage effects of polyA track engineered hypomorphs

  2021cites this paper
• Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53.

  2021influential citation
• Gene dosage effects of poly(A) track-engineered hypomorphs

  2021cites this paper
• PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer

  2021cites this paper
• KRAS signaling in malignant pleural mesothelioma

  2021cites this paper
• OTT_A_321949 4967..4978

  2021cites this paper
• Advanced Approaches to Breast Cancer Classification and Diagnosis

  2021cites this paper
• Untangling the crosstalk between BRCA1 and R-loops during DNA repair

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Myricetin Exerts its Apoptotic Effects on MCF-7 Breast Cancer Cells through Evoking the BRCA1-GADD45 Pathway

  2020cites this paper
• Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of BRCA1-Mutated Human Mammary Epithelial Cells

  2020cites this paper
• KRAS signalling in malignant pleural mesothelioma

  2020cites this paper
• The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?

  2019cites this paper
• Short-term effects of simulated microgravity on morphology and gene expression in human breast cancer cells.

  2019cites this paper
• Hypoxia Causes Transgenerational Impairment of Ovarian Development and Hatching Success in Fish.

  2019cites this paper
• Mechanisms of Genomic Instability in Breast Cancer.

  2019cites this paper
• Assessment of the expression of the BRCA1, BRCA2, TP53, MDM2, BAX and CASP-3 genes in normal and tumor tissues for patients with breast cancer in Morocco

  2018cites this paper
• BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression

  2018cites this paper
• Genomic Copy Number Alterations in Serous Ovarian Cancer

  2018cites this paper
• RNA metabolism proteins identified as ATM and 53BP1 partners function in the DDR

  2017cites this paper
• Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer

  2017cites this paper
• Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines

  2017cites this paper
• A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining

  2016cites this paper
• Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.

  2016cites this paper
• Identification of informative genes and pathways using an improved penalized support vector machine with a weighting scheme

  2016cites this paper
• Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple‐negative breast cancer, adversely affects survival

  2016cites this paper
• The effect of the level and timing of folic acid supplementation during the life course on the regulation of breast cancer determining genes, mammary morphology and implications for genome stability and tissue differentiation

  2016cites this paper
• p53 suppresses hyper-recombination by modulating BRCA1 function.

  2015cites this paper
• Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53

  2015cites this paper
• A Novel Radiation-Induced p53 Mutation Is Not Implicated in Radiation Resistance via a Dominant-Negative Effect

  2014cites this paper
• Serum p53 antibody in breast cancer

  2014cites this paper
• Mutants TP53 p.R273H and p.R273C but not p.R273G Enhance Cancer Cell Malignancy

  2014cites this paper
• The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis

  2014cites this paper
• Understanding at the molecular level the consequences of defective ATR signalling in humans

  2013cites this paper
• A guide for functional analysis of BRCA1 variants of uncertain significance

  2012cites this paper
• Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling

  2011influential citation
• One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor

  2011cites this paper
• The p53 response element and transcriptional repression

  2010cites this paper
• Identification and Characterization of Novel Kinases that Regulate BRCA1 Expression and Function

  2010cites this paper
• Altered Expression of Proliferation-Inducing and Proliferation-Inhibiting Genes Might Contribute to Acquired Doxorubicin Resistance in Breast Cancer Cells

  2009cites this paper
• Membrane‐bound melatonin receptor MT1 down‐regulates estrogen responsive genes in breast cancer cells

  2009cites this paper
• Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland

  2009cites this paper
• Discovery and Analysis of Genomic Patterns: Applications to Transcription Factor Binding and Genome Rearrangement

  2008cites this paper
• BRCA1-mediated ubiquitination inhibits topoisomerase II alpha activity in response to oxidative stress.

  2008cites this paper
• BRCA1-Mediated Ubiquitination Inhibits Topoisomerase IIα Activity in Response to Oxidative Stress

  2008cites this paper
• RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53

  2008cites this paper
• Altered gene expression profiles and higher frequency of spontaneous DNA strand breaks in APEX2-null thymus.

  2008cites this paper
• Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites

  2008cites this paper
• Conditional inactivation of the BRCA1 tumour suppressor gene in the mouse ovarian surface epithelium in vitro and in vivo

  2007cites this paper
• MOLECULAR STRESS SIGNALING IN BREAST EPITHELIAL CELLS Characterization of the Regulation of the Breast Cancer Susceptibility Gene 1 (BRCA1) by Stress Signaling and Design of an Epidemiological Study Examining the Effect of Glucocorticoid Receptor Genetic Variants on Breast Cancer Risk

  2007cites this paper
• p 63 – from expression to function studies of normal oral mucosa and squamous cell carcinoma of the head and neck

  2007cites this paper
• Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.

  2007cites this paper
• Insulin-like Growth Factor-I Controls BRCA1 Gene Expression through Activation of Transcription Factor Sp1

  2007cites this paper
• p53, BRCA1 and breast Cancer chemoresistance.

  2007cites this paper
• p63 – from expression to function : studies of normal oral mucosa and squamous cell carcinoma of the head and neck

  2007cites this paper
• BRCA1--a good predictive marker of drug sensitivity in breast cancer treatment?

  2006cites this paper
• CHK2-Dependent Phosphorylation of BRCA1 in Hypoxia

  2006cites this paper
• Caveolin‐1 controls BRCA1 gene expression and cellular localization in human breast cancer cells

  2006cites this paper
• Repression of New p53 Targets Revealed by ChIP on Chip Experiments

  2006cites this paper
• Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.

  2006cites this paper
• The PAAD domain OF IFI16 reveals a novel ssDNA binding function for the death domain super family

  2006cites this paper
• Transcriptional Activation by p53: Mechanisms and Targeted Genes

  2005cites this paper
• Mechanisms of tumour suppression and control of genomic integrity by BARD1

  2005cites this paper
• An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.

  2005cites this paper
• Expression of genes regulating chromosome segregation, the cell cycle and apoptosis during human preimplantation development.

  2005cites this paper
• A Molecular Model For Transcriptional Regulation of BRCA-1 Expression

  2005cites this paper
• Genotoxic stress: novel biomarkers and detection methods : Uncovering RNAs role in epigenetics of carcinogenesis

  2005cites this paper
• Altered expression of the ZBRK1 gene in human breast carcinomas

  2004cites this paper
• NDRG1 Is Necessary for p53-dependent Apoptosis*

  2004cites this paper
• Focused Review Series : BRCA 1 at 10 Years Since Discovery

  2004cites this paper
• Loss of BRCA1 expression in sporadic male breast carcinoma

  2004cites this paper
• DNA Damage Induces p53-dependent BRCA1 Nuclear Export*

  2004influential citation
• A Bicyclic Monoterpene Diol and UVB Stimulate BRCA1 Phosphorylation in Human Keratinocytes ¶

  2003cites this paper
• Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells.

  2003cites this paper
• BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest

  2003cites this paper
• Functional and Physical Interactions between BRCA1 and p53 in Transcriptional Regulation of the IGF-IR Gene

  2003cites this paper
• BRCA1 and p53: compensatory roles in DNA repair

  2003cites this paper
• p21/CDKN1A Mediates Negative Regulation of Transcription by p53*

  2003cites this paper
• An adenoviral vector containing an arg–gly–asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression

  2003cites this paper
• BRCA1 gene in breast cancer

  2003cites this paper
• p53 and regulation of DNA damage recognition during nucleotide excision repair.

  2003cites this paper
• BRCA1 in cancer, cell cycle and genomic stability.

  2003cites this paper